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Summary
Objective: To study in guinea pigs knee joints the effects of intra-articular injection of HYADD4-G (FidiaeFarmaceutici), a novel hyaluronan
(HA)-derived elastoviscous material and of Hyalgan (FidiaeFarmaceutici), a HA product with very low viscoelasticity, on movement-evoked
nociceptor impulse activity from normal and inﬂamed knee joints.
Design: Nociceptor impulse activity was recorded from single Ad and C ﬁbers of the medial articular nerve either under control conditions or
after induction of an experimental knee joint osteoarthritis (OA) by partial medial menisectomy and transection of the anterior cruciate ligament
(PMMeTACL). The stimuli consisted of standardized innocuous and noxious inward and outward rotations of the tibia against the femur of
50 s duration, repeated every 5 min for 1.5 h.
Results: The number of movement-evoked impulses was signiﬁcantly augmented 1 day and 1 week after PMMeTACL compared with intact
knee joint. The enhanced impulse response to joint movements 1 week following surgery was attenuated by repeated intra-articular injection of
HYADD4-G and even more prominently by Hyalgan.
Conclusions: HA products have a reducing action on joint nociceptor discharges that appears to depend predominantly on their role as an
elastoviscous ﬁlter associated with their rheological properties, but also on a chemical effect on sensitized nociceptive terminals of inﬂamed
joint tissues, possibly linked to the HA concentration.
ª 2008 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Hyaluronan (sodium hyaluronate, HA) is a glycosaminogly-
can present in joint tissues containing nerve terminals, i.e.,
synovial tissue and capsule, and also in the surface layer of
the cartilage and in synovial ﬂuid. This highly elastoviscous
polymer ﬁlls the intercellular space between the collagen ﬁ-
brillar network, surrounding all of the cells, the blood and
lymph vessels and the neural elements in the ﬁbrous tissue
of the joint1e3.
In arthritic conditions, elastoviscosity of the synovial
ﬂuid and tissue matrices is abnormally low2,3. Thus, elasto-
viscous solutions of HA with variable molecular mass
(0.5e6 million) have been injected intra-articularly, with
the aim of restoring the rheological homeostasis of the joint
in osteoarthritis (OA)3e5,7. This treatment was called visco-
supplementation3,5. Early human and equine clinical stud-
ies showed that with this treatment, the elastoviscosity of
the synovial ﬂuid returned to normal levels and simulta-
neously, the pain associated with the movement of the joint
decreased or was completely eliminated6,8,9.*Address correspondence and reprint requests to: Dr A. Gomis,
Instituto de Neurociencias de Alicante, Universidad Miguel
Herna´ndez-CSIC, San Juan de Alicante 03550, Spain.
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798It has been hypothesized that intra-articular HA applica-
tion causes analgesia by increasing the elastoviscosity of
the intercellular matrix of soft tissues around the joint,
thus providing a rheological buffer that reduces the force
transmitted during joint movements to the transducing
membrane elements at sensory nerve terminals innervating
the synovial lining and capsule. This proposal was sup-
ported by experimental studies showing that intra-articular
injection of high elastoviscous HA solutions produced a re-
duction of movement-induced nerve impulse activity in sin-
gle nociceptor ﬁbres of normal and acutely inﬂamed knee
joints of cats, rats and guinea pigs10e14. Molecular mass
of HA solutions seems to play an important role in this effect
because injection of non-elastoviscous solutions of low mo-
lecular mass did not cause a decrease of pain, nor of noci-
ceptor activity in experimental animals7,10,12.
The recording from single ﬁne articular afferents of the
knee joint while applying knee joint movements of deﬁned
torque15, opened up the possibility to evaluate quantitatively
the analgesic effects of HA preparations of various compo-
sitions on normal joints or on joints of animals subjected to
partial medial menisectomy (PMM) and transection of the
anterior cruciate ligament (TACL), a condition that has
been claimed to mimic an osteoarthritic condition. Consec-
utive to this surgery, joint inﬂammation was present as evi-
denced by an increase in knee joint diameter, possibly
reﬂecting an excess of volume of synovial ﬂuid (exudate)
that persisted for 3 weeks. In parallel, an augmented nerve
799Osteoarthritis and Cartilage Vol. 17, No. 6response to knee joint movement was observed 1 day and
1 week after surgery13. These responses were reduced by
Hylan G-F20 a highly viscous Hyaluronic acid preparation.
Likewise, a decrease of pain symptoms has been reported
after intra-articular injections of hyaluronic acid of different
rheology in osteoarthritic patients16e20.
In the present study, the PMMeTACL model of experi-
mentally-induced knee joint OA in guinea pigs was used
to evaluate the effect on movement-evoked impulse activity
of single knee joint nociceptive nerve ﬁbers, of a newly de-
veloped HA product of high elastoviscosity HYADD4-G21,
comparing its analgesic effects with those of Hyalgan,
a low elastoviscosity solution of higher HA concentration
but similar molecular weight.Material and methods
The study was performed on 117 guinea pigs of both sexes with ages
between 5 and 6 weeks at the time of surgery, weighing 400e450 g. In 50
animals more than one unit could be studied in the same experiment while
in the remaining 67 animals, one single ﬁber per experiment was recorded.
Animals were treated in accordance with institutional animal care guidelines.PMM AND TACL SURGERYPMM plus TACL were performed in the right hind limb, as a model to in-
duce joint inﬂammation, and joint instability leading to OA lesions22e29. In
brief, animals were anesthetized with an intramuscular injection of a mixture
of ketamine (50 mg/kg) and xilacine (10 mg/kg). Anesthesia was maintained
using isoﬂuorane (1-1.5%) mixed with 0.5 l of oxygen administered through
the respiratory circuit. An antero-medial approach to the joint was achieved
via a skin incision extending from the level of the distal third of the femur to
the proximal fourth of the tibia. The skin was retracted and the joint capsule
opened. The medial meniscus was identiﬁed and transected halfway
between its anterior and posterior horns. The anterior cruciate ligament
was transected afterwards. The joint capsule and the overlying fascia were
subsequently sutured.
Sham operated animals were treated identically except that transections
of the meniscus and of the anterior cruciate ligament were omitted.
To accelerate the recovery of the animals, they received an injection of
5 mg/kg atipamezol (a xilacine reversing agent). For 3 days after surgery,
subcutaneous injections of buprenorphine HCl (an analgesic acting at
CNS level) and enroﬂoxacine (an antibiotic) were applied per day. The
knee joint circumference was routinely measured before surgery and at
the onset of the experimental procedures for the recordings from the nerve
ﬁlaments of the various experimental groups. The animals were maintained
in the animal house for variable periods of time (from 24 h up to 1 week) prior
to the nerve recording session. During this time they were allowed to move
freely, drinking and eating ad libitum.RECORDING PROCEDURESThe animals were anaesthetized initially with an intramuscular injection of
a mixture of Ketamine (50 mg/kg) and Xilacine (10 mg/kg). Supplementary
doses of anesthetic were injected i.v as required. Animals were paralyzed
by the i.v. administration of 5 mg/100 g gallamine triethiodide i.v. (Sigma)
and artiﬁcially ventilated. Body temperature was kept around 37C with a ser-
voregulated heating pad.
All recordings were done on the right hindlimb. The surgical preparation
followed the routine pattern worked out in this laboratory over the last
years11e13,15. A tracheotomy was performed. Cannulations of the left femoral
vein and artery were also made to apply substances and to control blood
pressure. An additional ﬁne catheter was placed into the right saphenous
artery distal to the knee joint for close retrograde i.e., application of KCl into
the joint area.
Stabilization of the right femur was accomplished by ﬁxation with a special
grip, and a pool was formed using skin ﬂaps which was ﬁlled with warm par-
afﬁn oil. In this pool the whole medial part of the leg was exposed, including
the knee joint and the patellar ligament. A shoe-like holder for the hind paw
was connected to a lever via a metal rod equipped with a strain gauge and
a torque-meter (Hottinger Baldwin Messtechnik, Germany) to measure the
applied torque when performing inward and outward rotations of the calf
against the thigh.
The recording techniques were analogous to those used in previ-
ously12,13. In brief, the saphenous nerve was cut both in the inguinal region
and distally from the joint, leaving only the medial articular nerve intact. Fine
ﬁlaments were dissected at the proximal end of the nerve. After putting theﬁlaments over a silver wire electrode for extracellular recording, the receptive
ﬁelds of the afferent units were explored by recording the nerve impulse re-
sponses to mechanical stimuli evoked by probing the tissue over the knee
joint and its surroundings with a hand-held glass rod.
The afferent terminal of the nerve ﬁber so identiﬁed was electrically stim-
ulated (5e15 V, 0.5 ms) within its receptive ﬁeld to calculate the conduction
velocity from the latency of the evoked impulse and the distance between the
stimulating and recording electrodes. Nerve ﬁbers with conduction velocities
(CV) <2.5 m/s were classiﬁed as C ﬁbers, those with CV from 2.5 to 20 m/s
as Ad ﬁbers13.
In order to ensure that the units under observation were being reached by
the blood supply to the medial aspects of the knee joint and remained
functional, their discharges in response to a close intra-arterial bolus injection
of KCl (0.2 ml, 0.3 M, via the catheter in the A. saph., see above) were
observed at the end of the recording period.STIMULATING PROCEDURESThe mechano-sensitivity to knee joint movements of all articular afferent
units identiﬁed in this way was explored using a movement protocol
(see12), starting from the middle (the normal resting) position of the joint. It
consisted of a passive, manually performed outward rotation within the work-
ing range of the joint of 10 s duration (10e20 mNm, innocuous outward rota-
tion, [OR]) followed by an equally long outward rotation which exceeded the
normal working range of the joint (40e65 mNm, noxious outward rotation,
[NOR]). Thereafter, the joint was returned to the resting position for 10 s
and the same two steps were performed using innocuous and noxious in-
ward rotations [IR and NIR]. Such a complete movement cycle ([OR, NOR]
followed by [IR, NIR]) with a total duration of 50 s was repeated every
5 min (see plots in Figs. 1e3). The rotation called innocuous occurs in the
normal working range of the knee joint; it is not made against resistance
and it evokes a very discrete or no activity in joint afferent units15,30.EXPERIMENTAL DESIGNThe following eight experimental groups were made, according to the
treatment received (see also Table I)
Group 1. Healthy animals.
Group 2. Healthy animals that received one intra-articular injection of
saline solution 1 day before nerve recording.
Group 3. Healthy animals that received one intra-articular injection of
HYADD4-G 1 day before nerve recording.
Group 4. Animals with sham surgery performed 1 day and 1 week before
nerve recording.
Group 5. Animals with PMMeTACL surgery performed 1 day and 1 week
before nerve recording.
Group 6. Animals with PMMeTACL surgery together with immediate intra-
articular injection of HYADD4-G recorded 1 day after surgery, and ani-
mals with PMMeTACL surgery that received two intra-articular injections
of HYADD4-G, one at the end of the PMMeTACL surgery and one 3
days later (at day 4, i.e., at the third postoperative day). Articular nerve
ﬁber recording was performed 1 week after surgery.
Group 7. Animals with PMMeTACL surgery that received 2 intra-articular
injections of saline solution, one at the end of the PMMeTACL surgery and
one 3 days later. Articular nerve ﬁber recording was performed 1 week af-
ter surgery.
Group 8. Animals that received 2 intra-articular injections of Hyalgan so-
lution, one at the end of the PMMeTACL surgery and the second, 3 days
later. Articular nerve ﬁber recording was performed at day 7 after surgery.TEST MATERIAL(S) AND THEIR APPLICATIONTwo HA products were used: Hyalgan and HYADD4-G. Hyalgan is
a 10 mg/ml solution of 500e730 kDa average molecular weight hyaluronic
acid. HYADD4-G, is the hexadecylamide of hyaluronic acid of 500e730
kDa averagemolecular weight (5 mg/ml), obtained through chemicalmodiﬁca-
tion of 500e730 kDa averagemolecular weight hyaluronic acid by adding hex-
adecylamine (a primary aliphatic amine with 16 carbon atoms) to the
carboxylic group of glucuronic acid. According to the manufacturing company
FIDIAeFarmaceutici, the degree of modiﬁcation is very low (2%mol/mol), that
means that in HYADD4-G, of every 100 (disaccharide) units of hyaluronic
acid (N-acetyl glucosamine and D-glucuronic acid) only 2 have D-glucuronic
acid chemically modiﬁed by the covalent bound to the hexadecylamine. FIDIA
claims that this chemical modiﬁcation determines a relevant increase of the
viscoelastic properties in comparison to the starting Hyalgan and that at
2.5 Hz the elastic modulus of 5 mg/ml HYADD4-G is about 50 Pa while the
elastic modulus of Hyalgan is 0.6 Pa.
In this study, Hyalgan was used as available in the market, therefore at
10 mg/ml in phosphate buffered saline (PBS), while HYADD4-G was used
at a concentration of 5 mg/ml in PBS. 100 ml of the test material and of the
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Fig. 1. Movement-evoked activity in healthy knee joint afferents and in afferents 24 h after saline or HYADD4-G injection into the articular
cavity. (A) Squares: average number of impulses recorded from primary afferent units innervating healthy knee joints (n¼ 18); circles: those
of units from healthy knee joints which 1 day before recording received an intra-articular injection of 100 ml of saline (n¼ 10); and the triangles
are from units of joints which one day before recording received an intra-articular injection of 100 ml of HYADD4-G (n¼ 10). Each point plot-
ted shows the average S.E.M. of the total number of impulses obtained in single primary ﬁne afferent units during a complete movement cycle
i.e., ORþNORþ IRþNIR, each cycle starting 5 min after the previous one and lasting 50 s (see Methods for a detailed description of a move-
ment cycle) obtained. (B) The bar histograms illustrate the comparison between the three experimental conditions. The ** denote the signif-
icance for the treated animals vs control (One-way ANOVA; KruskaleWallis test P< 0.001).
800 A. Gomis et al.: Intra-articular injections of HA solutions of osteoarthritic knee joint of the guinea pigcontrol saline solution were injected into the joint space from the lateral side
using a 26 G needle. This was followed by passive knee joint movements to
facilitate the intra-articular distribution of the solution.ACTIVITY MEASUREMENTThe discharges recorded during the movements were analyzed by count-
ing separately the number of impulses evoked by each of the four move-
ments ORþNORþ IRþNIR. The regular observation was that the
change of the nerve activity, depending on the treatment group, occurred
both during movements performed within the working range and in the nox-
ious range. For this reason, we used the discharges recorded during the
complete movement cycle for presentation of the results. Plots and graphs
displayed in the ﬁgures were averaged from at least eight individual experi-
ments (for details see legends). The numbers of ﬁbers recorded in each
experimental condition is indicated in Table I.STATISTICSFor statistical evaluation, the total number of impulses obtained during the
complete cycle was used to represent the response to each individual move-
ment. They were then pooled to ﬁnd the mean S.E.M. representing the av-
erage response of each experimental group. Comparison between mean
values of the different experimental groups of animals was performed using
the One-way ANOVA. Individual values of knee joint circumferences before
and after surgery were compared using the Student’s paired t test. The
signiﬁcance level was set at P< 0.05 (*).ResultsGENERAL FINDINGSSuccessful recordings of appropriate duration (>90 min)
were obtained from 174 ﬁne afferent nerve ﬁbers of the
median articular nerve (MAN) of 117 animals belonging to
the various experimental groups. Most of the MAN nerve
ﬁbers of the guinea pig responding to movements of
the knee joint had CV that included them either into the
Ad (CV¼ 2.5e20 m/s, ﬁne myelinated ﬁbers) or the C
ﬁber group (CV¼<2.5 m/s, unmyelinated ﬁbers).
Unequivocal determination of the CV was possible for 62
Ad (mean CV¼ 3.8 0.2 m/s) and 68 C ﬁbers (mean
CV¼ 1.64 0.1 m/s). The number of C and Ad ﬁbers was
variable among groups making difﬁcult in some cases statis-
tical comparisons. Moreover, observed changes in nerve ac-
tivity with treatment occurred equally in Ad and C ﬁbers.Therefore data from Ad and C ﬁbers have been presented
jointly in the results.EFFECT OF HYADD4-G ON MOVEMENT-EVOKED ACTIVITY
IN HEALTHY KNEE JOINTSThe solid square symbols in Fig. 1(A) represent the aver-
age activity of 18 single units from healthy animals evoked
by innoxious (20 mN) and noxious (65 mN) outward and in-
ward rotations. Each point represents the average number
of impulses evoked by a complete movement cycle that
had a total duration of 50 s.
The ﬁlled triangles symbols in Fig. 1(A) show the move-
ment-evoked impulse activity measured in recordings per-
formed in 10 afferent ﬁbers, 24 h after intra-articular
injection of 100 ml of HYADD4-G while open circles repre-
sent the average, movement-evoked impulse discharge in
10 additional ﬁbers measured 24 h after injection of 100 ml
saline. To perform the injections into the joint cavity the an-
imals were brieﬂy sedated by an intramuscular injection of
ketamine. The bar histogram in Fig. 1(B) illustrates the sum-
marized results of these experiments, and show that both
types of intra-articular injections reduced in a signiﬁcant
way the average discharges of the primary afferent units
evoked by knee rotation. However, the injections of
HYADD4-G led to a much more pronounced discharge
decline than that of the saline application. Data are summa-
rized in Table I.MOVEMENT-EVOKED ACTIVITY IN PRIMARY KNEE JOINT
AFFERENTS AFTER SHAM e AND PMMeTACL e OPERATIONSThe open squares in Fig. 2(A) illustrate the data ob-
tained from 11 single ﬁne articular units after PMMeTACL
surgery performed one day before the beginning of the
electrophysiological recording. The black squares in this
plot display the results of 12 similarly conducted experi-
ments except that sham surgery was performed, (for de-
tails see Methods). Obviously the PMMeTACL surgery
led to a signiﬁcant increase (24% on average) in the
evoked afferent outﬂow from the ﬁne articular afferents
(Table I).
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Fig. 2. Movement-evoked activity in primary knee joint afferents
after shamand PMMTAC surgery. Stimulating, recording, evalu-
ating and plotting as in Fig. 1. (A) Average movement-evoked
activity in sham (solid squares; n ¼ 12) and in PMMTACL
(open squares; n¼ 11) operated animals recorded 1 day after sur-
gery. (B) Average movement-evoked activity in sham (solid circles;
n¼ 9) and in PMMTACL (open circles; n¼ 15) operated animals
recorded 1 week after surgery. (C) Summary of the averages of im-
pulses/movement cycle in the indicated experimental conditions.
The ** denote the signiﬁcance for the PMMTACL animals vs
sham animals (One-way ANOVA; Dunn’s methods; P< 0.001).
801Osteoarthritis and Cartilage Vol. 17, No. 6Figure 2(B) illustrates a set of similar experiments con-
ducted 1 week after the surgical procedures. 1 week after
PMMeTACL surgery there is, in comparison to the outﬂow
from the sham operated joints, still a considerable increase
in the evoked impulse outﬂow from the ﬁne articular afferents
(Table I). Results of these 2 sets of experiments are summa-
rized in the grey and white bar histograms of Fig. 2(C).MOVEMENT-EVOKED ACTIVITY AFTER INTRA-ARTICULAR
INJECTION OF HYADD4-G AND Hyalgan IN PMMeTACL KNEE
JOINTSWhen immediately after PMMeTACL surgery a dose of
100 ml of HYADD4-G was injected into the joint cavity
the afferent outﬂow recorded 1 day later was signiﬁcantly
reduced as illustrated by the ﬁlled triangles in Fig. 3(A)
and the grey bar histogram in Fig. 3(C) (n¼ 18). A compa-
rable result was obtained when HYADD4-G was given at
the time of operation and additionally at day 4, i.e., the third
postoperative day, and the neural activity was evaluated 1
week after the initial joint surgery (ﬁlled triangles in
Fig. 3(B), and white bar histogram, second from left, in
Fig. 3(C), n¼ 19). Both outﬂows are again in the same order
of magnitude and signiﬁcantly below those after PMMe
TACL surgery alone. Data are summarized in Table I. Injec-
tion of 100 ml saline instead of HYADD4-G immediately
after surgery and additionally at the third postoperative
day also caused a moderate reduction of impulse activity
after 1 week compared with untreated PMMeTACL animals
(see Table I). Still, the mean reduction of movement-evoked
activity 1 week after surgery in PMMeTACL animals treated
with HYADD4-G is signiﬁcantly larger than in animals
injected with saline.
To obtain comparative data with other clinically used
elastoviscous materials Hyalgan was injected immediately
after PMMeTACL surgery and at the third postoperative
day in another group of experiments. The average move-
ment-evoked afferent outﬂow recorded 1 week after surgery
from 16 ﬁne single afferent is signiﬁcantly lower than the ac-
tivity recorded in operated animals without treatment and in
animals treated with HYADD4-G. This result is summa-
rized in Fig. 3(C) (white bar histogram at the right end of
the graph) and in Table I.SPONTANEOUS ACTIVITYAs summarized in Table I, spontaneous impulse activity
was present in some ﬁbers of all experimental groups except
the group of healthy animals treated with saline and recorded
1 day after injection. Spontaneous activity appeared as occa-
sional impulses ﬁred during the interstimulus periods. The pat-
tern of spontaneous activity in these experimental groups
looked like that seen in our previous data13. The incidence
of spontaneous activity was low (always <1 Hz) and variable
in all experimental groups (17e52%, see Table I).VARIATION OF KNEE JOINT CIRCUMFERENCEConﬁrming previous observations13, knee joint diameter
increased signiﬁcantly after surgery both in sham operated
and PMMeTACL operated animals (Student’s paired t-test.
P< 0.001). Mean values in the different experimental
groups are summarized in Table I.
Discussion
The present results show that the new elastoviscous
compound HYADD4-G has an attenuating effect on
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Fig. 3. Movement-evoked activity after PMMTACL surgery re-
corded 1 day or 1 week later and having one respectively two post-
operative applications of either HYADD4-G or saline or Hyalgan.
Stimulating, recording, evaluating and plotting as in Fig. 1. (A) Av-
erage movement-evoked activity recorded 1 day after surgery in
PMMTACL operated animals (squares; n¼ 11) and in animals
which in addition to the PMMTACL surgery received an injection
of HYADD4-G (solid triangles, n¼ 18) immediately after surgery.
802 A. Gomis et al.: Intra-articular injections of HA solutions of osteoarthritic knee joint of the guinea pigmovement-evoked nerve impulse activity from intact knee
joints of guinea pigs and also from joints in which an exper-
imental joint injury was induced by partial medial menisec-
tomy and section of the anterior cruciate ligament. An
even more marked attenuation of the activity was also ob-
tained with Hyalgan, used for viscosupplementation treat-
ment in human OA19.
Hyalgan is constituted by 500e730 kDa averagemolecular
weight hyaluronic acid and has a very low elastic modulus 12.
HYADD4-G is equally composed by hyaluronic acid of
500e730 kDa but chemically modiﬁed by adding hexadecyl-
amine at a low degree of substitution (2% mol/mol). The man-
ufacturer (FidiaeFarmaceutici) claims that this chemical
modiﬁcation does not cause crosslinking, but the presence
of the hexadecylamine determines the formation of additional
interactions in the polymer that markedly modiﬁes the rheolog-
ical properties of the starting hyaluronic acid, thus making this
HA derivative more viscous and elastic. Therefore it has been
possible in this study to compare the nociceptive effect of two
hyaluronic acid products of the same molecular weight with
different viscoelasticity21.
Our work shows that HYADD4-G was effective in reduc-
ing the excitatory effects of moderate and strong mechani-
cal forces on the impulse activity in ﬁne medial articular
nerve afferents of the intact guinea pig knee joint. Similar ef-
fects have been described in intact and acutely inﬂamed rat
knee joints with a HA solution of high elastoviscosity, Hylan
G-F 20, while low elastoviscosity materials as Hyalgan
were ineffective12 thus supporting the interpretation that
the elastic and viscous properties of polymer solutions like
HA play an important role through their pseudoplastic and
molecular shock absorber properties in the intact joint31.
The elastoviscous behavior reported for HYADD4-G
predicts that this substance also absorbs part of the me-
chanical energy of the stimulus. This would reduce the
transmission of force to the mechanotransduction appara-
tus at peripheral nociceptive endings, thus decreasing the
stimulus force and the response of knee joint sensory ﬁbers
to mechanical forces, as was actually observed in the
present experiments.
HYADD4-G and Hyalgan also reduced signiﬁcantly the
augmented impulse activity seen in operated guinea pigs, 1
day and 1 week after PMM and TACL. In animals with
PMMeTACL-induced injury nociceptive discharges evoked
by movement remained enhanced only during the early
postsurgery period. This suggests that augmented activity
is due to a sensitization of joint nociceptors secondary to
the inﬂammatory reaction induced by the surgical trauma,
but probably also by cartilage damage that is already ob-
served 1e2 weeks following surgery32,33. The attenuation
by HYADD4-G of this effect cannot be attributed primarily
to the elastoviscous buffering action of this substance on
mechanical forces transmitted to nociceptive endings(B) The graphs correspond to those in (A), but the recordings
were done 1 week after PMMTACL surgery. The circles plot the
results obtained after surgery alone (n¼ 15), and the triangles
give the results obtained when HYADD4-G (n¼ 19) was applied
immediately after surgery and at the third postoperative day. (C)
Bar histograms of the results plotted in (A) and (B) as indicated
by the lettering. The third white bar at the extreme right shows
the average movement-evoked afferent outﬂow 1 week after
PMMTACL surgery from 16 units where Hyalgan was injected
immediately after surgery and at the third postoperative day. The
** denote the signiﬁcance for the PMMTACL operated animals
vs those with additional applications as indicated (One-way
ANOVA P< 0.001).
Table I
Mean values of the number of impulses per movement cycle and number of fibers and animals used in each group are indicated. Also the
spontaneous activity recorded in the different experimental groups is shown. The presence of spontaneous activity was consider when the
number of impulses per second was higher than 0.05. Last column indicate average of the knee joint circumference measured immediately
before surgery and at the day of the recording
Experimental groups Average number
of impulses/movement
cycle (S.E.M.)
No. of ﬁbers/No.
of animals
Fibers presenting
spontaneous activity
(imp/s> 0.05)
Joint circumference
(cm) Before/After
PMMeTACL
1 Healthy animals 211 3 18/16 4/18 e
2 Healthy animalsþ saline 1 day 191 1.1 10/6 0/10 e
3 Healthy animalsþHYADD4-G 1 day 73 1 10/5 3/10 e
4 Sham operated 1 day 198 4 12/10 5/12 6.5 0.1/7.5 0.3
1 week 126 1.5 9/9 2/9 6.5 0.3/7.1 0.2
5 PMMeTACL 1 day 246 2.3 11/7 2/11 6.7 0.2/7.5 0.2
1 week 239 4 15/10 2/15 6.9 0.2/7.7 0.1
6 PMMeTACLþHYADD4-G 1 day 193 2 18/10 3/18 6.3 0.1/7.6 0.2
1 week 183 2.2 19/9 10/19 6.3 0.1/7.2 0.2
7 PMMTACLþ saline 1 week 218 3.3 8/5 2/8 6.2 0.1/7.5 0.3
8 PMMeTACLþHyalgan 1 week 98 2.2 16/10 3/16 6.5 0.3/7.6 0.1
803Osteoarthritis and Cartilage Vol. 17, No. 6because our work now shows that 1 week after surgery,
Hyalgan was even more effective than HYADD4-G in
spite of its low elastoviscosity perhaps due to its compara-
tively higher concentration in HA molecules.
It has been repeatedly suggested that part of the analge-
sic effect of HA products is due to their binding with the cell
membrane receptors and/or chemical interaction with
inﬂammatory mediators released by injured tissues and by
inﬂammatory cells 1,34e37. Chemical interaction with inﬂam-
matory mediators could explain the marked reduction of im-
pulse activity both with HYADD4-G and Hyalgan 1 week
after surgery seen in the present experiments.
Surprisingly, saline injection also attenuated slightly the
enhanced activity evoked by surgery, perhaps through dilu-
tion of locally released inﬂammatory mediators. This result
could be interpreted as the neurophysiological correlate of
the slight but evident reduction in pain experienced by pa-
tients with intra-articular injection of placebo or when knee
washing is combined with viscosupplementation therapy38.
It is expected that inﬂammatory agents play a minor role
in the modulation of movement-evoked nociceptor activity in
intact knee joints but may signiﬁcantly contribute to its
sensitization when inﬂammation is present as was the
case in the present study, judging by the increased knee
joint diameter found in operated animals.
The PMMeTACL OA model was aimed at mimicking the
symptoms of OA. However, nociceptive discharges
evoked by movement in animals after PMMeTACL, were
augmented only during the early postsurgery period, pos-
sibly reﬂecting the sensitization of nociceptive afferent
units innervating knee joint tissues caused by the inﬂam-
matory reaction secondary to surgery. 1 to 2 weeks after
PMMeTACL surgery, cartilage damage is evident32,33.
Therefore a contribution to joint inﬂammation of joint insta-
bility and altered mechanics cannot be excluded. Nonethe-
less, the observed changes in impulse activity of knee joint
nociceptor ﬁbers in the PMMeTACL OA model do not
closely reproduce the characteristics and time course of
pain experienced by human patients suffering from
OA12,13,39. Thus, extrapolation of the attenuating action
on joint nociceptor activity of locally injected HA deriva-
tives in PMMeTACL-induced OA to the analgesic action
of these compounds seen in human OA must be made
with caution. Taking these limitations into account, it ap-
pears reasonable to speculate that HA products have a di-
rect reducing effect on joint nociceptor activity in part due
to its role as a mechanical ﬁlter that is associated to itsrheological properties but also to chemical interaction
with inﬂammatory mediators present in the inﬂamed joint
tissues, thus reducing their sensitizing effect on nociceptor
terminals.Conﬂict of interest
None of the authors have any commercial interest asso-
ciate to the products tested or personal relationships with
other people or organisations that could inappropriately
inﬂuence (bias) their work.
Acknowledgments
We thank E. Quintero and A. Pe´rez Vegara for technical as-
sistance and to Dr. Antonella Schiavinato for critical reading
of the manuscript. This work was supported by funds from
FIDIA (Italy), and by grants BFU2005-08741 (CB) and
BFU2005-03986 (AG) and CONSOLIDER-INGENIO 2010
CSD2007-00023 to C.B., from the Spanish Ministry of Sci-
ence and Education.References
1. Balazs EA, Darzynkiewicz Z. The effect of hyaluronic acid on ﬁbroblast,
mononuclear phagocytes and ymphocytes. In: Kulonen E,
Pikkarainen J, Eds. Biology of the Fibroblast. London: Academic
Press; 1973:237e52.
2. Balazs EA. The physical properties of synovial ﬂuid and the special role
of hyaluronan acid. In: Helfet A, Ed. Disorders of the Knee.
Philadelphia: J.B. Lippincott; 1982:61e74.
3. Balazs EA, Denlinger JL. Clinical uses of hyaluronan. Ciba Found Symp
1989;143:265e75.
4. Balazs EA, Denlinger JL. Viscosupplementation: a new concept in the
treatment of osteoarthritis. J Rheumatol Suppl 1993;39:3e9.
5. Adams ME. Viscosupplementation as articular therapy. Perspective. In:
Laurent T, Ed. The Chemistry, Biology and Medical Applications of Hy-
aluronan and its Derivatives. London: Portland Press; 1996:243e53.
6. Weiss C. Hyaluronan and hylan in the treatment of osteoarthritis. In:
Kennedy JF, Phillips GO, Williams PA, Hascall VC, Eds. Hyaluronan.
Cambridge: Woodhead; 2002:467e82.
7. Balazs EA. Analgesic effect of elastoviscous hyaluronan solutions and
the treatment of arthritic pain. Cells Tissues Organs 2003;174:49e62.
8. Rydell N, Balazs EA. Effect of intra-articular injection of hyaluronic acid
on the clinical symptoms of osteoarthritis and on granulation tissue
formation. Clin Orthop Relat Res 1971;80:25e32.
9. Peyron JG,BalazsEA. Preliminary clinical assessment of Na-hyaluronate
injection into human arthritic joints. Pathol Biol (Paris) 1974;22:731e6.
10. Pozo MA, Balazs EA, Belmonte C. Reduction of sensory responses to
passive movements of inﬂamed knee joints by hylan, a hyaluronan
derivative. Exp Brain Res 1997;116:3e9.
804 A. Gomis et al.: Intra-articular injections of HA solutions of osteoarthritic knee joint of the guinea pig11. Pawlak M. Mechanoprotective actions of elastoviscous hylans on artic-
ular pain receptors. In: Kennedy JF, Phillips GO, Williams PA,
Hascall VC, Eds. Hyaluronan. Cambridge: Woodhead; 2002:341e52.
12. Gomis A, Pawlak M, Balazs EA, Schmidt RF, Belmonte C. Effects of
different molecular weight elastoviscous hyaluronan solutions on
articular nociceptive afferents. Arthritis Rheum 2004;50:314e26.
13. Gomis A, Miralles A, Schmidt RF, Belmonte C. Nociceptive nerve activ-
ity in an experimental model of knee joint osteoarthritis of the guinea
pig: effect of intra-articular hyaluronan application. Pain 2007;130:
126e36.
14. Belmonte C, Pozo MA, Balazs EA. Modulation by hyaluronan and its de-
rivatives (hylans) of sensory nerve activity signalling articular pain. In:
Laurent TC, Ed. The Chemistry, Biology and Medical Applications of
Hyaluronan and its Derivatives. London: Portland Press; 1998:
205e17.
15. Just S, Pawlak M, Heppelmann B. Responses of ﬁne primary afferent
nerve ﬁbres innervating the rat knee joint to deﬁned torque. J Neurosci
Methods 2000;103:157e62.
16. Bellamy N, Campbell J, Robinson V, Gee T, Bourne R, Wells G.
Viscosupplementation for the treatment of osteoarthritis of the knee.
Cochrane Database Syst Rev 2006:CD005321.
17. Adams ME, Atkinson MH, Lussier AJ, Schulz JI, Siminovitch KA,
Wade JP, et al. The role of viscosupplementation with hylan G-F 20
(Synvisc) in the treatment of osteoarthritis of the knee: a Canadian
multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with
non-steroidal anti-inﬂammatory drugs (NSAIDs) and NSAIDs alone.
Osteoarthritis Cartilage 1995;3:213e25.
18. Waddell DD, Cefalu CA, Bricker DC. A second course of hylan G-F 20
for the treatment of osteoarthritic knee pain: 12-month patient follow-
up. J Knee Surg 2005;18:7e15.
19. Altman RD, Moskowitz R. Intraarticular sodium hyaluronate (Hyalgan) in
the treatment of patients with osteoarthritis of the knee: a randomized
clinical trial. Hyalgan Study Group. J Rheumatol 1998;25:2203e12.
20. Dougados M, Nguyen M, Listrat V, Amor B. High molecular weight
sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1 year
placebo-controlled trial. Osteoarthritis Cartilage 1993;1:97e103.
21. Borzacchiello A, Mayol L, Schiavinato A, Ambrosio L. Effect of a hyalur-
onic acid amide derivative on equine synovial ﬂuid viscoelasticity.
J Biomed Mater Res A (In press).
22. Telhag H, Lindberg L. A method for inducing osteoarthritic changes in
rabbits’ knees. Clin Orthop Relat Res 1972;86:214e23.
23. Moskowitz RW, Davis W, Sammarco J, Martens M, Baker J, Mayor M,
et al. Experimentally induced degenerative joint lesions following
partial meniscectomy in the rabbit. Arthritis Rheum 1973;16:
397e405.
24. Pond MJ, Nuki G. Experimentally-induced osteoarthritis in the dog. Ann
Rheum Dis 1973 July;32:387e8.
25. Gilbertson EM. Development of periarticular osteophytes in experimen-
tally induced osteoarthritis in the dog. A study using microradiographic,microangiographic, and ﬂuorescent bone-labelling techniques. Ann
Rheum Dis 1975;34:12e25.
26. Brandt KD, Braunstein EM, Visco DM, O’Connor B, Heck D, Albrecht M.
Anterior (cranial) cruciate ligament transection in the dog: a bona ﬁde
model of osteoarthritis, not merely of cartilage injury and repair.
J Rheumatol 1991 March;18:436e46.
27. Karahan S, Kincaid SA, Kammermann JR, Wright JC. Evaluation of the
rat stiﬂe joint after transection of the cranial cruciate ligament and
partial medial meniscectomy. Comp Med 2001;51:504e12.
28. Tessier JJ, Bowyer J, Brownrigg NJ, Peers IS, Westwood FR,
Waterton JC, et al. Characterisation of the guinea pig model of oste-
oarthritis by in vivo three-dimensional magnetic resonance imaging.
Osteoarthritis Cartilage 2003;11:845e53.
29. Anderson-MacKenzie JM, Quasnichka HL, Starr RL, Lewis EJ,
Billingham ME, Bailey AJ. Fundamental subchondral bone changes
in spontaneous knee osteoarthritis. Int J Biochem Cell Biol 2005;37:
224e36.
30. Schaible HG, Schmidt RF. Activation of groups III and IV sensory units
in medial articular nerve by local mechanical stimulation of knee joint.
J Neurophysiol 1983;49:35e44.
31. Pena EL, Sala S, Rovira JC, Schmidt RF, Belmonte C. Elastoviscous
substances with analgesic effects on joint pain reduce stretch-acti-
vated ion channel activity in vitro. Pain 2002;99:501e8.
32. Appleton CT, McErlain DD, Pitelka V, Schwartz N, Bernier SM,
Henry JL, et al. Forced mobilization accelerates pathogenesis: char-
acterization of a preclinical surgical model of osteoarthritis. Arthritis
Res Ther 2007;9:R13.
33. Hayami T, Pickarski M, Zhuo Y, Wesolowski GA, Rodan GA, Duong lT.
Characterization of articular cartilage and subchondral bone changes
in the rat anterior cruciate ligament transection and meniscectomized
models of osteoarthritis. Bone 2006;38:234e43.
34. Gotoh S, Miyazaki K, Onaya J, Sakamoto T, Tokuyasu K, Namiki O.
Experimental knee pain model in rats and analgesic effect of sodium
hyaluronate (SPH). Nippon Yakurigaku Zasshi 1988;92:17e27.
35. Frean SP, Lees P. Effects of polysulfated glycosaminoglycan and
hyaluronan on prostaglandin E2 production by cultured equine syno-
viocytes. Am J Vet Res 2000;61:499e505.
36. Akatsuka M, Yamamoto Y, Tobetto K, Yasui T, Ando T. In vitro effects of
hyaluronan on prostaglandin E2 induction by interleukin-1 in rabbit
articular chondrocytes. Agents Actions 1993;38:122e5.
37. Punzi L, Schiavon F, Cavasin F, Ramonda R, Gambari PF, Todesco S.
The inﬂuence of intra-articular hyaluronic acid on PGE2 and cAMP of
synovial ﬂuid. Clin Exp Rheumatol 1989;7:247e50.
38. Vad VB, Bhat AL, Sculco TP, Wickiewicz TL. Management of knee
osteoarthritis: knee lavage combined with hylan vs hylan alone.
Arch Phys Med Rehabil 2003;84:634e7.
39. Denlinger JL. Metabolism of sodium hyaluronate in articular and ocular
tissues. Doctoral dissertation. France: Universite´ des Sciences et
Techniques de Lille, Lille, 1982, p. 327.
